Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
HYPERTENSION DIAGNOSTICS INC (HDII)
|
Add to portfolio |
|
|
|
| Price: |
$0.01
| | Metrics |
| OS: |
52.4
|
M
| |
|
|
| Market cap: |
$466.3
|
k
| |
|
|
|
Net cash:
|
$86.4
|
k
| |
$0.00
|
per share
|
|
EV:
|
$379.9
|
k
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($1.6)
|
M
| |
|
|
|
EBIT
|
($1.6)
|
M
| |
|
|
| EPS |
($0.02)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Jun-30-12 | Jun-30-11 | Jun-30-10 | Sep-18-09 | Jun-30-09 |
| Revenues | 3.8 | 3.7 | 3.6 | 0.0 | 0.0 | 1,383.7 | | 0.5 |
| Revenue growth | 3.1% | 3.1% | | | -100.0% | 274887.6% | | -99.9% |
| Cost of goods sold | 5.7 | 5.9 | 6.0 | 3.2 | 0.0 | 194.3 | | 0.3 |
| Gross profit | -1.9 | -2.2 | -2.5 | -3.2 | 0.0 | 1,189.4 | | 0.2 |
| Gross margin | -49.7% | -59.1% | -69.1% | -15573.6% | | 86.0% | | 43.4% |
| Selling, general and administrative | 0.9 | 1.0 | 1.0 | 1.2 | 0.4 | 2,402.8 | | 0.6 |
| EBIT | -0.2 | -0.4 | -0.7 | -1.4 | -0.4 | -999.2 | | -0.3 |
| EBIT margin | -4.2% | -11.0% | -18.4% | -6668.4% | | -72.2% | | -52.0% |
| Pre-tax income | -0.1 | -0.4 | -0.6 | 0.0 | 0.0 | -989.8 | | -0.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | | | 0.0% | | 0.0% |
| Net income | -0.1 | -0.4 | -0.6 | 0.0 | 0.0 | -989.8 | | -0.2 |
| Net margin | -3.3% | -10.0% | -17.4% | 0.0% | | -71.5% | | -49.4% |
| |
| Diluted EPS | | | | $0.00 | $0.00 | ($23.98) | | ($0.01) |
| Shares outstanding (diluted) | | | | 54.2 | 50.0 | 41.3 | | 40.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|